Y Intercept (Hong Kong) LTD Bausch Health Companies Inc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$7.77 - $10.61 $314,179 - $429,015
-40,435 Reduced 27.66%
105,765 $1.12 Million
Q4 2023

Feb 13, 2024
BUY
$6.53 - $8.23 $954,686 - $1.2 Million
146,200 New
146,200 $1.17 Million
Q2 2022

Aug 08, 2022
BUY
$7.06 - $23.63 $345,883 - $1.16 Million
48,992 New
48,992 $410,000
Q2 2021

Aug 12, 2021
SELL
$27.43 - $32.7 $342,847 - $408,717
-12,499 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$21.37 - $34.38 $267,103 - $429,715
12,499 New
12,499 $490,000

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email